Detalhe da pesquisa
1.
Risk factors for serious infections in ANCA-associated vasculitis.
Ann Rheum Dis
; 82(5): 681-687, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702528
2.
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.
Ann Rheum Dis
; 82(7): 937-944, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958796
3.
SARS-COV-2 vaccine responses in renal patient populations.
BMC Nephrol
; 23(1): 199, 2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641961
4.
Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models.
Rheumatology (Oxford)
; 60(3): 1491-1501, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141217
5.
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.
Ann Rheum Dis
; 79(9): 1243-1249, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581088
6.
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis.
J Clin Rheumatol
; 25(5): 217-223, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30896460
7.
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
Lancet
; 399(10327): 800-802, 2022 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065703
8.
Response to: 'Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'' by Parikh et al.
Ann Rheum Dis
; 82(1): e24, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542105
9.
Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.
Ann Rheum Dis
; 77(10): 1440-1447, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950327
10.
Avacopan for ANCA-associated vasculitis - information for prescribers.
Nephrol Dial Transplant
; 38(5): 1067-1070, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496198
11.
Introduction to the European Vasculitis Society 3rd International Vasculitis Course (Cambridge) case-based supplement.
Rheumatology (Oxford)
; 60(Suppl 3): iii1-iii5, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137887
12.
Extracorporeal membrane oxygenation for life-threatening ANCA-associated vasculitis with pulmonary haemorrhage.
Rheumatology (Oxford)
; 60(Suppl 3): iii54-iii56, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137870
13.
Fever on an airline flight: a diagnostic challenge.
Rheumatology (Oxford)
; 60(Suppl 3): iii21-iii23, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137882
14.
Cardiac decompensation revealing giant cell arteritis.
Rheumatology (Oxford)
; 60(Suppl 3): iii9-iii11, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137883
15.
Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
J Autoimmun
; 57: 60-5, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556904
16.
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
J Autoimmun
; 57: 24-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586449
17.
Introduction to the European Vasculitis Society 3rd International Vasculitis course (Cambridge, 23-25 September 2019) supplement.
Rheumatology (Oxford)
; 59(Suppl 3): iii1-iii4, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348515
18.
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Rheumatology (Oxford)
; 54(7): 1153-60, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25477054
19.
The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.
BMC Musculoskelet Disord
; 15: 178, 2014 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24884562
20.
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis Rheum
; 64(11): 3760-9, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22729997